Home
News
Screeners
Insights
Sai Parenteral's
547.
50
+12.55
(+2.35%)
Market Cap
₹2,418.81 Cr
PE Ratio
165.70
Industry
Healthcare
Buy
Sell
Company Performance:
1D
+2.35%
1M
-6.94%
6M
+34.95%
1Y
+34.95%
5Y
+34.95%
View Company Insights
Latest news about Sai Parenteral's
Sai Parenterals appoints auditors for FY27 and authorizes growth
Jul 07, 2026
Sai Parenterals Limited appointed M/s. Aakanksha Dubey & Co. as Secretarial Auditors for 2026-27 to 2030-31, subject to shareholder approval. The board also appointed M/s. NSVR & Associates LLP as Internal Auditors and M/s. Sai Krishna & Associates as Cost Auditors for FY 2026-27. Additionally, Mr. Anil Kumar Karusala was authorized to explore organic and inorganic growth opportunities.
Sai Parenterals subsidiary wins AUD 202 Mn OTC order
Jul 02, 2026
Sai Parenterals to host virtual analyst meet on Jul 2
Jul 01, 2026
Sai Parenterals targets ₹750 crore revenue in FY27
May 30, 2026
Sai Parenterals secures $11 million anti-TB supply order
May 29, 2026
More news about Sai Parenteral's
28
May 26
Sai Parenterals FY26 PAT rises 45.5% to ₹14.37 Cr
Sai Parenterals reported FY26 PAT of ₹14.37 crore, up 45.5%, driven by CDMO exports and the Noumed acquisition. Consolidated revenue surged 140.4% to ₹380.99 crore.
Sai Parenteral's
547.
50
+
12.
55
(+
2.
35
%)
1 Year Returns:
+34.95%
Industry Peers
Sun Pharmaceutical
1,990.50
(-
0.
53
%)
Divis Laboratories
8,056.00
(+
2.
82
%)
Torrent Pharmaceuticals
5,122.80
(+
5.
15
%)
Cipla
1,473.20
(+
0.
46
%)
Zydus Life Science
1,126.80
(+
1.
05
%)
Lupin
2,415.00
(-
0.
26
%)
Mankind Pharma
2,469.60
(-
4.
13
%)
Laurus Labs
1,816.20
(+
1.
96
%)
Dr Reddys Laboratories
1,148.10
(+
0.
29
%)
Aurobindo Pharma
1,580.20
(+
0.
25
%)
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO
Cyclical Trend
Events Calendar